Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer’s disease

[1]  M. Schocke,et al.  Energy Metabolism Measured by 31P Magnetic Resonance Spectroscopy in the Healthy Human Brain. , 2021, Journal of neuroradiology = Journal de neuroradiologie.

[2]  Jeffrey S. Spence,et al.  Phosphate Brain Energy Metabolism and Cognition in Alzheimer’s Disease: A Spectroscopy Study Using Whole-Brain Volume-Coil 31Phosphorus Magnetic Resonance Spectroscopy at 7Tesla , 2021, Frontiers in Neuroscience.

[3]  C. Boesch,et al.  31P magnetic resonance spectroscopy in skeletal muscle: Experts' consensus recommendations , 2020, NMR in biomedicine.

[4]  Klaus Scheffler,et al.  Double‐tuned 31P/1H human head array with high performance at both frequencies for spectroscopic imaging at 9.4T , 2020, Magnetic resonance in medicine.

[5]  L. Squarcina,et al.  In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson’s Disease , 2019, Metabolites.

[6]  Y. Fujiwara,et al.  Longitudinal effects of aging on 18F-FDG distribution in cognitively normal elderly individuals , 2018, Scientific Reports.

[7]  J. Whitwell,et al.  Alzheimer's disease neuroimaging , 2018, Current opinion in neurology.

[8]  Heinrich Lanfermann,et al.  Effects of Aging on the Human Brain: A Proton and Phosphorus MR Spectroscopy Study at 3T , 2018, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[9]  K. Kantarci,et al.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action , 2018, Alzheimer's & Dementia.

[10]  Arend Heerschap,et al.  Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional 31P MR spectroscopic imaging study , 2018, NeuroImage: Clinical.

[11]  Lucian A B Purvis,et al.  Using a whole-body 31P birdcage transmit coil and 16-element receive array for human cardiac metabolic imaging at 7T , 2017, PloS one.

[12]  C. Jack,et al.  Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study , 2017, The Lancet Neurology.

[13]  Nicolas G. R. Behl,et al.  Iterative reconstruction of radially-sampled 31P bSSFP data using prior information from 1H MRI. , 2017, Magnetic resonance imaging.

[14]  L. de Bari,et al.  A disease with a sweet tooth: exploring the Warburg effect in Alzheimer’s disease , 2017, Biogerontology.

[15]  Chengjie Xiong,et al.  Imaging and cerebrospinal fluid biomarkers in early preclinical alzheimer disease , 2016, Annals of neurology.

[16]  Keith A. Johnson,et al.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.

[17]  Ryan Brown,et al.  Magnetic Resonance Imaging of Phosphocreatine and Determination of BOLD Kinetics in Lower Extremity Muscles using a Dual-Frequency Coil Array , 2016, Scientific Reports.

[18]  Stefan Neubauer,et al.  Dilated Cardiomyopathy: Phosphorus 31 MR Spectroscopy at 7 T , 2016, Radiology.

[19]  J. Ardenkjaer-Larsen,et al.  Simultaneous PET/MRI with 13C magnetic resonance spectroscopic imaging (hyperPET): phantom-based evaluation of PET quantification , 2016, EJNMMI Physics.

[20]  T. Scheenen,et al.  Repeatability of 31P MRSI in the human brain at 7 T with and without the nuclear Overhauser effect , 2016, NMR in biomedicine.

[21]  Karthik Lakshmanan,et al.  A nested phosphorus and proton coil array for brain magnetic resonance imaging and spectroscopy , 2016, NeuroImage.

[22]  P. Murali Doraiswamy,et al.  Marked gender differences in progression of mild cognitive impairment over 8 years , 2015, Alzheimer's & dementia.

[23]  Pierre J. Magistretti,et al.  Alzheimer's disease: the amyloid hypothesis and the Inverse Warburg effect , 2014, Front. Physiol..

[24]  Yi Li,et al.  FDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer’s Disease , 2014, Advances in molecular imaging.

[25]  A. Dale,et al.  Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers , 2013, American Journal of Neuroradiology.

[26]  Ravinder R Regatte,et al.  3D‐mapping of phosphocreatine concentration in the human calf muscle at 7 T: Comparison to 3 T , 2013, Magnetic resonance in medicine.

[27]  Stefan Neubauer,et al.  Human cardiac 31P magnetic resonance spectroscopy at 7 tesla , 2013, Magnetic resonance in medicine.

[28]  S. Vallabhajosula,et al.  Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents , 2013, Neurobiology of Aging.

[29]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[30]  Cindee M. Madison,et al.  Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI , 2011, Neurobiology of Aging.

[31]  U. Ziemann,et al.  Combined 1H and 31P spectroscopy provides new insights into the pathobiochemistry of brain damage in multiple sclerosis , 2011, NMR in biomedicine.

[32]  Michael W. Weiner,et al.  Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans , 2010, Neurobiology of Aging.

[33]  Nicholas Lange,et al.  Age‐related changes in brain energetics and phospholipid metabolism , 2010, NMR in biomedicine.

[34]  S. de Santi,et al.  Increased fibrillar amyloid-β burden in normal individuals with a family history of late-onset Alzheimer’s , 2010, Proceedings of the National Academy of Sciences.

[35]  Carola Seifried,et al.  Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. , 2009, Brain : a journal of neurology.

[36]  Jeffrey A. Fessler,et al.  Reducing between scanner differences in multi-center PET studies , 2009, NeuroImage.

[37]  Rachel L. Mistur,et al.  Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease , 2009, Neurology.

[38]  T. Neumann-Haefelin,et al.  Combined 1H and 31P MR spectroscopic imaging: impaired energy metabolism in severe carotid stenosis and changes upon treatment , 2009, Magnetic Resonance Materials in Physics, Biology and Medicine.

[39]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[40]  Rachel L. Mistur,et al.  Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism , 2007, Proceedings of the National Academy of Sciences.

[41]  W. Martin,et al.  MR Spectroscopy in Neurodegenerative Disease , 2007, Molecular Imaging and Biology.

[42]  Wei Chen,et al.  Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain , 2007, Magnetic Resonance in Medicine.

[43]  H P Hetherington,et al.  4 T Actively detuneable double-tuned 1H/31P head volume coil and four-channel 31P phased array for human brain spectroscopy. , 2006, Journal of magnetic resonance.

[44]  N. Bresolin,et al.  Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[45]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[46]  Wei Chen,et al.  Measurement of unidirectional Pi to ATP flux in human visual cortex at 7 T by using in vivo 31P magnetic resonance spectroscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[48]  J. Baron,et al.  Mild cognitive impairment , 2003, Neurology.

[49]  K. Uğurbil,et al.  In vivo 31P magnetic resonance spectroscopy of human brain at 7 T: An initial experience , 2003, Magnetic resonance in medicine.

[50]  V J Cunningham,et al.  Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study. , 2000, Brain : a journal of neurology.

[51]  E. Perry,et al.  α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease , 1999 .

[52]  B. Barbiroli,et al.  Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease , 1999, Movement Disorders.

[53]  B D Ross,et al.  Quantitative proton-decoupled 31P MRS and 1H MRS in the evaluation of Huntington's and Parkinson's diseases , 1998, Neurology.

[54]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[55]  Charles D. Smith,et al.  Frontal lobe phosphorus metabolism and neuropsychological function in aging and in alzheimer's disease , 1995, Annals of neurology.

[56]  T R Brown,et al.  NOE Enhancements and T1 Relaxation Times of Phosphorylated Metabolites in Human Calf Muscle at 1.5 Tesla , 1995, Magnetic resonance in medicine.

[57]  A. Palmer,et al.  Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease , 1994, Brain Research.

[58]  J. Pettegrew,et al.  Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study , 1994, Neurobiology of Aging.

[59]  P. Zaniol,et al.  Brain Oxidative Metabolism in Parkinson's Disease Studied by Phosphorus 31 Magnetic Resonance Spectroscopy , 1993 .

[60]  C. Grady,et al.  An in vivo study of phosphorus and glucose metabolism in Alzheimer's disease using magnetic resonance spectroscopy and PET. , 1993, Archives of general psychiatry.

[61]  C J Hardy,et al.  Alzheimer dementia: quantification of energy metabolism and mobile phosphoesters with P-31 NMR spectroscopy. , 1992, Radiology.

[62]  C. Hardy,et al.  Proton overhauser enhancements in human cardiac phosphorus NMR spectroscopy at 1.5 T , 1992, Magnetic resonance in medicine.

[63]  W. J. Lorenz,et al.  In vivo nuclear overhauser effect in 31P‐ {1H} double‐resonance experiments in a 1.5‐T whole‐body MR system , 1990, Magnetic resonance in medicine.

[64]  P R Luyten,et al.  Broadband proton decoupling in human 31p NMR spectroscopy , 1989, NMR in biomedicine.

[65]  N. Minshew,et al.  31P Nuclear Magnetic Resonance Studies of Phosphoglyceride Metabolism in Developing and Degenerating Brain: Preliminary Observations , 1987, Journal of neuropathology and experimental neurology.

[66]  J. Hawthorne,et al.  Reduced Phosphoinositide Concentrations in Anterior Temporal Cortex of Alzheimer‐Diseased Brains , 1987, Journal of neurochemistry.

[67]  D. Gadian,et al.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study. , 1983, Molecular biology & medicine.

[68]  Sex and Gender Differences in Alzheimer's Disease , 2021 .

[69]  M. Mielke.  Sex and Gender Differences in Alzheimer's Disease Dementia. , 2018, The Psychiatric times.

[70]  Claire Henchcliffe,et al.  Usefulness of Proton and Phosphorus MR Spectroscopic Imaging for Early Diagnosis of Parkinson's Disease , 2015, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[71]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[72]  C. Segebarth,et al.  Quantitative 31P MRS of the normal adult human brain. Assessment of interindividual differences and ageing effects , 1993, NMR in biomedicine.

[73]  C. Maerschalk,et al.  Spin-lattice relaxation times and nuclear Overhauser enhancement effect for 31P metabolites in model solutions at two frequencies: implications for in vivo spectroscopy. , 1990, Magnetic resonance imaging.